DudeDiligence.

Quoin Pharmaceuticals, Ltd

QNRXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

Shares on issue

168.1M

From 3.98M in June 2024

a raise that quarter, at its price

Newest

$150.0M

S-3 of 2026-10-28. 1 prospectus supplement filed under it since.

$11.0M

Leerink Partners, agreement of 2026-11-04. No at-the-market sales on file.

Warrants

10.24M

Priced warrants: 10.24M at $10.59.

Cash

7.1 quarters

$33.2M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-04Public offeringnot availablenot availablenot available424B5 ↗
2025-10-10Private placementnot availablenot available$16.6M8-K ↗
2024-12-20Public offering incl. 11.97M pre-funded, with warrants at $0.4515,111,110$0.45$6.8M424B4 ↗

Also on file: a 1-for-20 reverse split, 2025-04-08 8-K ↗ · a 1-for-35 reverse split, 2025-04-09 8-K ↗